Positive Phase 1b Data Confirms Overdose Protection for Highest Dosage Form of PF614-MPAR ~ SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 /, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a ...

SeaStar Medical plans to conduct an interim analysis at the trial's 90-day primary endpoint with the first 100 subjects. Given the current pace of enrollment, the company anticipates a Data Safety ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

The solution integrates Longboat's clinical trial technology with Advarra's study startup programme and single sign-on ...

The FDA issues a warning letter to Sanofi over manufacturing violations at its Massachusetts site, citing contamination and ...

The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

People are to be sent from Oxford to the Netherlands to be deliberately infected with a form of malaria so scientists can study its effects. Plasmodium vivax is a type of malaria that can remain ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

The rescinded orders include directives boosting the Affordable Care Act exchanges, coordinating the government’s COVID-19 ...

Advarra, a leader in regulatory review solutions and clinical research technology, has unveiled its Study Collaboration ...

Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...